Auris Medical to Report First Half 2020 Financial Results and Provide Business Update on Thursday, September 17, 2020
September 11 2020 - 8:00AM
Hamilton, Bermuda, September 11, 2020 – Auris
Medical Holding Ltd. (NASDAQ: EARS), a clinical-stage company
dedicated to developing therapeutics that address important unmet
medical needs in neurotology and central nervous system disorders,
today announced that it will provide a business update and report
its financial results for the first half 2020 on Thursday,
September 17, 2020. Following the announcement, Auris Medical's
management team will host a live conference call and webcast at
8:30 am Eastern Time (2:30 pm Central European Time).
To participate in this conference call, dial
1-877-870-9135 (US toll free) or +44 2071
928 338 (international), and enter passcode
5286195. A live webcast of the conference call can
be accessed in the Investor Relations section of the Auris Medical
website at www.aurismedical.com. A replay will be available
approximately two hours following the live call.
About Auris Medical
Auris Medical is a biopharmaceutical company
dedicated to developing therapeutics that address important unmet
medical needs in neurotology and CNS disorders. The Company is
focused on the development of intranasal betahistine for the
treatment of vertigo (AM-125, in Phase 2) and for the prevention of
antipsychotic-induced weight gain and somnolence (AM-201, post
Phase 1b). With AM-301, the Company is developing a nasal spray for
protection against airborne pathogens and allergens. In addition
Auris Medical has two Phase 3 programs under development: Sonsuvi®
(AM-111) for acute inner ear hearing loss and Keyzilen® (AM-101)
for acute inner ear tinnitus. The Company was founded in 2003 and
is headquartered in Hamilton, Bermuda with its main operations in
Basel, Switzerland. The shares of Auris Medical Holding Ltd. trade
on the NASDAQ Capital Market under the symbol “EARS.”
Investor contact:
Joseph Green Edison Advisor for Auris Medical 646-653-7030
jgreen@edisongroup.com
or
investors@aurismedical.com
Auris Medical (NASDAQ:EARS)
Historical Stock Chart
From Mar 2024 to Apr 2024
Auris Medical (NASDAQ:EARS)
Historical Stock Chart
From Apr 2023 to Apr 2024
